Ac-Asp-Arg-Leu-Asp-Ser-OH |
| Catalog No.GA20491 |
The acetylated pentapeptide Ac-DRLDS inhibits tumor cell adhesion to laminin, fibronectin, vitronectin, and RGDS-IgG substrates. Ac-DRLDS also inhibits tumor cell adhesion to CS-1-IgG as well as the CS-1-derived peptide (EILDV) (H-2592), in a concentration-dependent manner. Although the inhibitory effect was less than that of EILDV, this peptide retains the properties of both RGDS and EILDV.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 153959-57-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
The acetylated pentapeptide Ac-DRLDS inhibits tumor cell adhesion to laminin, fibronectin, vitronectin, and RGDS-IgG substrates. Ac-DRLDS also inhibits tumor cell adhesion to CS-1-IgG as well as the CS-1-derived peptide (EILDV), in a concentration-depe
Average Rating: 5 (Based on Reviews and 19 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *